- Raised $1.4M Seed round, May 2023
- Raised $500k grant, Mar 2023
- Raised $800k Pre-Seed round, Dec 2021
About
SignaLife is an Israeli startup that develops non-invasive, continuous optical monitoring solutions for real-time blood pH and blood gas assessment aimed at ICU, NICU and obstetric use. The company's mission is to provide real-time, AI-driven blood gas and pH monitoring solutions for ICU and NICU patients, empowering healthcare providers with reliable insights for better patient outcomes. They utilize artificial intelligence combined with physics in their technology. SignaLife is led by a team of experienced professionals dedicated to advancing healthcare through innovative, non-invasive monitoring solutions. With expertise across business development, medical innovation, and R&D, their leaders bring decades of experience from life sciences, healthcare, and medical device industries.
Funding history · 3 rounds · $2.7M total
Q&A
- What is SignaLife's primary focus?
- SignaLife is a technology company developing non-invasive continuous blood gas and pH sensors using AI optic technology for medical and well-being use.
- What is the status of SignaLife's clinical trials?
- SignaLife has shown high accuracy in initial results from its first in human trial in Assuta Ashdod ICU. A second clinical trial in Sheba Medical Center’s NICU recruited its first baby in April 2025, with promising pH results.
- What is SignaLife's total funding to date?
- SignaLife has raised a total of $2,700,000 across multiple funding rounds.
- When was SignaLife founded?
- SignaLife was founded in March 2021.
- Which investors have participated in SignaLife's funding rounds?
- In April 2023, SignaLife received a grant from the Israel Innovation Authority.
- What is SignaLife's current employee count?
- SignaLife currently has 1-10 employees.
- Who are the co-founders of SignaLife?
- The co-founders of SignaLife are Yaron Cherny, who serves as CEO, and Roy Nissim, who serves as CSO.
- What problem do SignaLife's solutions address?
- SignaLife's solutions aim to provide non-invasive, reliable measurements, reducing infection risk, minimizing blood draws, and supporting better treatment decisions for patients hospitalized in the ICU and NICU.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | signalife.com/ |
|---|---|
| linkedin.com/company/101222372/ |
Identifiers & details
| Legal name | SIGNALIFE LTD |
|---|---|
| Founded | 2021-3 |
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 6 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | signalife.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516358363 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-03-08 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (2) |
| Registered address | עיר שמש 37 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-09 | הקצאת מניות |
| 2025-10-09 | הגדלה של הון רשום |